Skip to main content
OpenTrials

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,958 public trials 634 recruiting studies
Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Completed

BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma

NCT01034631

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Northwest Alabama Cancer Center Muscle Shoals, Alabama, United States
  • Genesis Cancer Center Hot Springs, Arkansas, United States
  • Providence Health System: Roy and Patricia Disney Family Cancer Center Burbank, California, United States
  • Compassionate Cancer Care Medical Group, Inc. Corona, California, United States
View all 108 locations
View Trial Details
Completed

Phase 2 Study of Docetaxel +/- OGX-427 in Patients With Relapsed or Refractory Metastatic Bladder Cancer

NCT01780545

Conditions
Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +14 more
Locations
  • University of Alabama Hematology Oncology Clinic at Medical West Birmingham, Alabama, United States
  • City of Hope: Duarte Duarte, California, United States
  • City of Hope: Antelope Valley Lancaster, California, United States
  • USC: Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 35 locations
View Trial Details
Completed

An Investigational Immuno-Therapy Safety and Efficacy Study of Multiple Administration Regimens for Nivolumab Plus Ipilimumab in Subjects With Renal Cell Carcinoma

NCT03029780

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Cancer Specialists of North FL Jacksonville, Florida, United States
  • University Of Iowa Hospitals And Clinics Iowa City, Iowa, United States
  • Levine Cancer Institute Charlotte, North Carolina, United States
  • Local Institution Pittsburgh, Pennsylvania, United States
View Trial Details
Completed

Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery

NCT00777491

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Georgia Cancer Center for Excellence at Grady Memorial Hospital Atlanta, Georgia, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center Boise, Idaho, United States
  • Cancer Institute at St. John's Hospital Springfield, Illinois, United States
View Trial Details
Completed

Trebananib With or Without Bevacizumab, Pazopanib Hydrochloride, Sorafenib Tosylate, or Sunitinib Malate in Treating Patients With Advanced Kidney Cancer

NCT01664182

Conditions
Adenocarcinoma, Advanced Renal Cell Carcinoma, Advanced Sarcomatoid Renal Cell Carcinoma, +17 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • City of Hope South Pasadena South Pasadena, California, United States
View Trial Details

Related conditions